NCT05620706View on ClinicalTrials.gov

Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2028

Conditions

Advanced Hepatocellular Carcinoma

Interventions

BIOLOGICAL

GPC3 CAR-T cells

patients treated with GPC3 CAR-T cells

Trial Locations (1)

518000

RECRUITING

Li Yu, Shenzhen

All Listed Sponsors

lead

Shenzhen University General Hospital

OTHER